Katherine M Iverson1, Christina M Dardis2, Terri K Pogoda3. 1. Women's Health Sciences Division of the National Center for PTSD, VA Boston Healthcare System, 150 South Huntington Avenue (116B-3), Boston, MA, 02130, United States; Department of Psychiatry, Boston University School of Medicine, 72 East Concord Street, Boston, MA, 02118, United States. Electronic address: katherine.iverson@va.gov. 2. Women's Health Sciences Division of the National Center for PTSD, VA Boston Healthcare System, 150 South Huntington Avenue (116B-3), Boston, MA, 02130, United States; Department of Psychiatry, Boston University School of Medicine, 72 East Concord Street, Boston, MA, 02118, United States. 3. Center for Healthcare Organization and Implementation Research, VA Boston Healthcare System, 150 S. Huntington Avenue (Building 9), Boston, MA, 02130, United States; Department of Health Law, Policy & Management, Boston University School of Public Health, 715 Albany Street, Boston, MA, 02118, United States.
Abstract
OBJECTIVE: To effectively diagnose and treat women who have experienced intimate partner violence (IPV), it is important to identify the full range of physical and mental health consequences, including hidden wounds such as traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD). We aimed to identify the occurrence of IPV-related TBI and associated PTSD symptoms among women veterans who experienced IPV. METHODS: A web-based survey was administered in 2014 to a national sample of U.S. women veterans. Among 411 respondents (75% participation rate), 55% reported IPV during their lives. These participants (N=224) completed screening measures of IPV-related TBI, PTSD, and past-year IPV and comprised the current sample. RESULTS: A total of 28.1% (n=63) met criteria for IPV-related TBI history, and 12.5% (n=28) met criteria for IPV-related TBI with current symptoms. When adjusting for race, income, and past-year IPV, women with IPV-related TBI with current symptoms were 5.9 times more likely to have probable IPV-related PTSD than those with no IPV-related TBI history. Despite symptom overlap between TBI and PTSD, women with IPV-related TBI with current symptoms were significantly more likely to meet criteria for all four DSM-5 PTSD symptom clusters compared to women with an IPV-related TBI history without current symptoms (Cramér's V's=.34-.42). CONCLUSION: Findings suggest there may be clinical utility in screening women who experience lifetime IPV for both TBI and PTSD symptoms in order to help clinicians better target their examinations, treatment, and referrals. Published by Elsevier Inc.
OBJECTIVE: To effectively diagnose and treat women who have experienced intimate partner violence (IPV), it is important to identify the full range of physical and mental health consequences, including hidden wounds such as traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD). We aimed to identify the occurrence of IPV-related TBI and associated PTSD symptoms among women veterans who experienced IPV. METHODS: A web-based survey was administered in 2014 to a national sample of U.S. women veterans. Among 411 respondents (75% participation rate), 55% reported IPV during their lives. These participants (N=224) completed screening measures of IPV-related TBI, PTSD, and past-year IPV and comprised the current sample. RESULTS: A total of 28.1% (n=63) met criteria for IPV-related TBI history, and 12.5% (n=28) met criteria for IPV-related TBI with current symptoms. When adjusting for race, income, and past-year IPV, women with IPV-related TBI with current symptoms were 5.9 times more likely to have probable IPV-related PTSD than those with no IPV-related TBI history. Despite symptom overlap between TBI and PTSD, women with IPV-related TBI with current symptoms were significantly more likely to meet criteria for all four DSM-5 PTSD symptom clusters compared to women with an IPV-related TBI history without current symptoms (Cramér's V's=.34-.42). CONCLUSION: Findings suggest there may be clinical utility in screening women who experience lifetime IPV for both TBI and PTSD symptoms in order to help clinicians better target their examinations, treatment, and referrals. Published by Elsevier Inc.
Authors: Zohre Ahmadabadi; Jackob M Najman; Gail M Williams; Alexandra M Clavarino; Peter d'Abbs; Nam Tran Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2020-01-07 Impact factor: 4.328
Authors: Galina A Portnoy; Mark R Relyea; Candice Presseau; Skye Orazietti; Steve Martino; Cynthia A Brandt; Sally G Haskell Journal: J Head Trauma Rehabil Date: 2022 Jan-Feb 01 Impact factor: 2.710
Authors: Rebecca B Lawn; Shaili C Jha; Jiaxuan Liu; Laura Sampson; Audrey R Murchland; Jennifer A Sumner; Andrea L Roberts; Seth G Disner; Francine Grodstein; Jae H Kang; Laura D Kubzansky; Lori B Chibnik; Karestan C Koenen Journal: Depress Anxiety Date: 2021-12-30 Impact factor: 6.505
Authors: Carrie Esopenko; Jessica Meyer; Elisabeth A Wilde; Amy D Marshall; David F Tate; Alexander P Lin; Inga K Koerte; Kimberly B Werner; Emily L Dennis; Ashley L Ware; Nicola L de Souza; Deleene S Menefee; Kristen Dams-O'Connor; Dan J Stein; Erin D Bigler; Martha E Shenton; Kathy S Chiou; Judy L Postmus; Kathleen Monahan; Brenda Eagan-Johnson; Paul van Donkelaar; Tricia L Merkley; Carmen Velez; Cooper B Hodges; Hannah M Lindsey; Paula Johnson; Andrei Irimia; Matthew Spruiell; Esther R Bennett; Ashley Bridwell; Glynnis Zieman; Frank G Hillary Journal: Brain Imaging Behav Date: 2021-01-06 Impact factor: 3.978
Authors: Eve M Valera; Annie-Lori C Joseph; Katherine Snedaker; Matthew J Breiding; Courtney L Robertson; Angela Colantonio; Harvey Levin; Mary Jo Pugh; Deborah Yurgelun-Todd; Rebekah Mannix; Jeffrey J Bazarian; L Christine Turtzo; Lyn S Turkstra; Lisa Begg; Diana M Cummings; Patrick S F Bellgowan Journal: J Head Trauma Rehabil Date: 2021-01-01 Impact factor: 3.117
Authors: Brandon Lucke Wold; Richard Nolan; Divine Nwafor; Linda Nguyen; Cletus Cheyuo; Ryan Turner; Charles Rosen; Robert Marsh Journal: J Neurosci Neuropharmacol Date: 2018-03-02